scholarly article | Q13442814 |
P356 | DOI | 10.1016/0888-7543(91)90041-C |
P698 | PubMed publication ID | 1664411 |
P50 | author | James F. Gusella | Q1602688 |
P2093 | author name string | Housman DE | |
Altherr MR | |||
Wasmuth JJ | |||
Schalling M | |||
Thompson LM | |||
Plummer S | |||
P433 | issue | 4 | |
P921 | main subject | Huntington's disease | Q190564 |
P304 | page(s) | 1133-1142 | |
P577 | publication date | 1991-12-01 | |
P1433 | published in | Genomics | Q5533503 |
P1476 | title | A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. | |
P478 | volume | 11 |
Q24314986 | A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome |
Q61996079 | A gene for achondroplasia–hypochondroplasia maps to chromosome 4p |
Q72257353 | A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia |
Q34723178 | Achondroplasia is defined by recurrent G380R mutations of FGFR3 |
Q42526678 | Acidic fibroblast growth factor mRNA is expressed by basal forebrain and striatal cholinergic neurons |
Q34377947 | Advances in research on and diagnosis and treatment of achondroplasia in China. |
Q34482525 | Analysis of the sheep genome |
Q36850692 | Antisense transcription of a murine FGFR-3 psuedogene during fetal developement |
Q48395285 | Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system |
Q35250259 | Autosomal dominant postaxial polydactyly, nail dystrophy, and dental abnormalities map to chromosome 4p16, in the region containing the Ellis-van Creveld syndrome locus |
Q35804009 | Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms |
Q47432960 | Central nervous system phenotypes in craniosynostosis |
Q36569482 | Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells |
Q36390066 | Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells |
Q41099724 | Delimiting the Wolf-Hirschhorn syndrome critical region to 750 kilobase pairs |
Q40795919 | Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations |
Q45979021 | Distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin II: distribution in human adult fibroblasts. |
Q30857433 | Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder |
Q28609662 | Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation |
Q45291040 | Exclusion of DNA changes in the beta-subunit of the c-GMP phosphodiesterase gene as the cause for Huntington's disease |
Q28213608 | Expressed genes, Alu repeats and polymorphisms in cosmids sequenced from chromosome 4p16.3 |
Q41537489 | FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry |
Q48110292 | FGFR3 mutations and medial temporal lobe dysgenesis |
Q35229509 | Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction |
Q40425812 | Fibroblast growth factors in mammalian development |
Q41491086 | Fibroblast growth factors, their receptors and receptor disorders |
Q41616468 | Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line |
Q37103542 | Genetic analysis of sporadic and familial interstitial pneumonia |
Q32128060 | Genomic structure and complete sequence of the human FGFR4 gene |
Q28079309 | Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application |
Q51948729 | Malignant hematological disorders in children with Wolf–Hirschhorn syndrome |
Q35195824 | Molecular definition of the smallest region of deletion overlap in the Wolf-Hirschhorn syndrome |
Q46439667 | Mutations affecting multiple functional domains of FGFR3 cause different skeletal dysplasias: a personal retrospective in honor of John Wasmuth |
Q45345175 | Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia |
Q56899514 | New nucleotide sequence data on the EMBL File Server |
Q41861013 | New overgrowth syndrome and FGFR3 dosage effect |
Q37786089 | Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer |
Q72345845 | Positional cloning moves from perditional to traditional |
Q30333303 | Purification of a heparin binding FGF receptor (HB-FGFR) from adult bovine brain membranes |
Q41065090 | Radiation-induced DNA double-strand breaks and the radiosensitivity of human cells: a closer look |
Q51919647 | Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia. |
Q72997859 | Smad mediates BMP-2-induced upregulation of FGF-evoked PC12 cell differentiation |
Q45289080 | Synteny conservation of the Huntington's disease gene and surrounding loci on mouse Chromosome 5. |
Q45345166 | Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. |
Q58277086 | The Molecular Basis of Hereditary Skeletal Disorders |
Q33918556 | The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts |
Q41180639 | The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF. |
Q72017465 | The gene for achondroplasia maps to the telomeric region of chromosome 4p |
Q24316938 | Variable subcellular localization of a neuron-specific protein during NTera 2 differentiation into post-mitotic human neurons |
Search more.